Experiment 440337

Worktypes

REVIEW OFANTICANCER AND/OR CYTOTOXICITY MARKER CODEPHARMACOLOGY OF COMPOUND - IN HUMANS

Compounds isolated

TAXOL

Alerts

THESE DATA ARE FROM A REVIEW ARTICLE.A MIXTURE OF PURE COMPOUNDS WAS USED TO OBTAIN THE REPORTED EFFECT.

Details

PropertyValue
Pharmacology
ANTITUMOR ACTIVITY
Administration routeIV INFUSION
OrganismEmpty organism
CitationHOLMES,FA:. (1993). TAXOL, SINGLE-AGENT AND COMBINATION THERAPY, FOR METASTATIC BREAST CANCER.. 11(1)
Amount utilized
Compound isolated
DiseaseDISCUSSED IN THIS REVIEW ARTICLE ARE 2 PHASE STUDIES, SEVERAL PHASE 1 STUDIES, 2 OF WHICH EVALUATED TAXOL TREATMENT IN COMBINATION WITH DOXORUBICIN AND SEVERAL IN VITRO STUDIES WITH TAXOL ALONE AND IN COMBINATION WITH DOXORUBICIN. TAXOL TREATMENT IN COMBINATION WITH DOXORUBICIN PROVED MORE EFFECTIVE IN THE TREATMENT OF CANCERS BOTH IN VIVO AND IN VITRO.
Dose amountVAR
Number1
Qualitative result.
AnimalHUMAN ADULT
Dose expressionDOSE